IL6 and familial pancreatic carcinoma: However, the relationship between baseline IL-6 levels in treatment-naïve patients with advanced pancreatic cancer and their subsequent prognosis, as well as the effectiveness of systemic chemotherapy and its connection with systemic inflammatory markers, remains largely unexplored.